Metabolite product from pomegranate: Researchers identify way to boost tumor-fighting immune cells
Researchers have succeeded in identifying a new approach for the therapy of colorectal cancer. In preclinical models and studies on human immune cells, they found that urolithin A, a metabolite product from pomegranate, sustainably improves the function of immune cells in their fight against cancer. After treatment with urolithin A, tumour-fighting immune cells become T memory stem cells which, due to their ability to divide, constantly supply the immune system with rejuvenated, non-exhausted T cells.
Materials provided by Goethe University Frankfurt. Note: Content may be edited for style and length.
Source link aaaaa
